[EN] DOPAMINE D2 RECEPTOR LIGANDS<br/>[FR] LIGANDS DU RÉCEPTEUR D2 DE LA DOPAMINE
申请人:BROAD INST INC
公开号:WO2016100823A1
公开(公告)日:2016-06-23
The present invention relates to novel dopamine D2 receptor ligands. The invention further relates to functionally-biased dopamine D2 receptor ligands and the use of these compounds for treating or preventing central nervous system and systemic disorders associated with dysregulation of dopaminergic activity.
Enantioselective<i>ortho</i>-CH Cross-Coupling of Diarylmethylamines with Organoborons
作者:Brian N. Laforteza、Kelvin S. L. Chan、Jin-Quan Yu
DOI:10.1002/anie.201505204
日期:2015.9.14
The commonly used para‐nitrobenzenesulfonyl (nosyl) protecting group is employed to direct the CH activation of amines for the first time. An enantioselective ortho‐CH cross‐coupling between nosyl‐protected diarylmethylamines and arylboronic acid pinacol esters has been achieved utilizing chiral mono‐N‐protected amino acid (MPAA) ligands as a promoter.
作者:Yao-Yao Liu、Yuan-Lu Qu、Yan-Shang Kang、Yue-Lu Zhu、Wei-Yin Sun、Yi Lu
DOI:10.1021/acs.orglett.2c00620
日期:2022.5.6
Herein, the Rh-catalyzed consecutive C–H bond olefination/annulation/olefination cascade, tandemly directed by sulfonamide and ester groups, has been developed under mild conditions with the assistance of 1-adamantane carboxylic acid. A seven-membered metallacycle including an ester group was preferred to the five-membered one including a sulfonamide group for the third C–Hactivation. In this transformation
Catalytic Enantioselective Nucleophilic Addition to Arynes by a New Quaternary Guanidinium Salt-Based Phase-Transfer Catalyst
作者:Guihua Pan、Maoping Pu、Hongyu Wang、Meijia Ying、Yi Li、Shunxi Dong、Xiaoming Feng、Xiaohua Liu
DOI:10.1021/jacs.3c09594
日期:2023.12.6
in situ generated fluoride-based chiral phase-transfer catalyst. In this study, we present a catalytic enantioselective nucleophilicaddition reaction involving arynes, utilizing an amino amide-based guanidinium salt QG•X. Furthermore, we demonstrate the broad compatibility of this reaction with various arynes and cyclic/acyclic β-keto amides, leading to the creation of diverse α-aryl quaternary stereocenters
The present invention relates to novel dopamine D2 receptor ligands. The invention further relates to functionally-biased dopamine D2 receptor ligands and the use of these compounds for treating or preventing central nervous system and systemic disorders associated with dysregulation of dopaminergic activity.